Identifying molecular pathways affected by the sporadic ALS risk factor, GGNBP2 (2019–2020)

Grant type:
Motor Neurone Disease Research Institute of Australia Inc
Researchers:
Funded by:
Motor Neurone Disease Research Institute of Australia Inc